Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $12.8 million.

  • Tandem Diabetes Care's Change in Accured Expenses fell 1850.02% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 6135.88%. This contributed to the annual value of $20.9 million for FY2024, which is 30369.65% up from last year.
  • Latest data reveals that Tandem Diabetes Care reported Change in Accured Expenses of $12.8 million as of Q3 2025, which was down 1850.02% from $1.1 million recorded in Q2 2025.
  • Tandem Diabetes Care's Change in Accured Expenses' 5-year high stood at $15.8 million during Q3 2024, with a 5-year trough of -$40.9 million in Q4 2022.
  • For the 5-year period, Tandem Diabetes Care's Change in Accured Expenses averaged around $1.6 million, with its median value being $1.2 million (2024).
  • Per our database at Business Quant, Tandem Diabetes Care's Change in Accured Expenses plummeted by 104299.22% in 2022 and then skyrocketed by 11248571.43% in 2024.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Change in Accured Expenses stood at $4.3 million in 2021, then tumbled by 1042.99% to -$40.9 million in 2022, then skyrocketed by 99.01% to -$404000.0 in 2023, then skyrocketed by 1475.99% to $5.6 million in 2024, then soared by 131.08% to $12.8 million in 2025.
  • Its last three reported values are $12.8 million in Q3 2025, $1.1 million for Q2 2025, and -$13.7 million during Q1 2025.